Edvince is open for partnering discussions. Our strategy is to find a competent partner after completion of the phase 1/2 trial with the capacity to develop and commercialize the product to the benefit of patients suffering from subarachnoid hemorrhage.

For further information, please contact Dr. Tore Duvold.

Tore Duvold, CEO
M: +4561905066
[email protected]